Press Release
| 4 Min Read

Iodine Software Announces Robin Damschroder Joins Board


MARCH 15, 2021 — AUSTIN, Tx. — Iodine Software today announced that it has appointed Robin Damschroder, Executive Vice President and Chief Financial Officer at Henry Ford Health System to its board. 

“We are pleased to welcome Robin to the Iodine board, especially during such a pivotal time in our growth trajectory,” said William Chan, CEO and Co-founder, Iodine Software. “She joins Iodine at an exciting time as we continue to further cement our place as one of the leading clinical documentation improvement solutions in the industry. Robin’s leadership experience at some of the nation’s largest health systems will prove invaluable to our future growth strategy.”

Robin Damschroder, MHSA, FACHE is Executive Vice President and Chief Financial Officer of Henry Ford Health System, a $6.5Bn health system that includes six hospitals, seven major medical centers and manages more than 650,000 covered lives. She also served as the COO, West Market – Saint Joseph Mercy Health System and has held various executive financial and operations leadership roles at University of Michigan Health System. She holds two degrees from the University of Michigan, Ann Arbor, MI – a bachelor’s in General Studies from College of Literature, Science and Arts, and a Master’s of Health Services Administration from the School of Public Health.

Iodine Software has seen record growth over the past year, unveiling the AwareCDI Suite in 2020 and receiving the top overall performance score in the 2021 KLAS Clinical Documentation Improvement (CDI) Report. Looking ahead, the company will continue to leverage the latest in AI and machine learning to help organizations achieve their desired financial, operational, and quality outcomes and build financially resilient organizations for years to come.


About Iodine Software

Iodine Software is a healthcare AI company that has pioneered a new machine learning approach — Cognitive EmulationTM — to help healthcare finance leaders build resilient organizations. Founded in 2010, Iodine’s technology unifies clinical concepts, evidence-based medicine, and deep machine learning to power revenue cycle solutions that maximize capture and data accuracy. To date, the Iodine AwareCDITM Suite has helped hospitals recognize $1.5 billion in additional appropriate reimbursement annually. To learn more, visit